Originally published byEU-Startups
ScreenPoint Medical, a Nijmegen-based Breast AI company focusing on breast cancer detection and risk assessment, has raised €11.9 million ($14 million) in new funding from existing investors, global software investor Insight Partners and Siemens Healthineers. It has also secured €1.7 million ($2 million) in non-dilutive research grants. With this funding, the company aims to support […]
The post Insight Partners-backed ScreenPoint Medical secures €13.6 million to advance AI-powered breast cancer detection appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
Securing the Untrusted Agentic Development Layer
Just now
The hottest cities for robotics deals in Europe
18h ago
What 2,800 funding rounds reveal about how startups spend money
18h ago
Würzburg-based NanoStruct raises €2.6 million to detect harmful bacteria in food within hours
17h ago
Debian 14 cracks down on unreproducible packages
6h ago